STAT3 and plasma cell myeloma: One key consequence of JAK-STAT activation is overactivity of STAT3, a STAT family transcription factor which results in high expression of the antiapoptotic protein Bcl-xL [94], a protein correlated to chemoresistance in myeloma patients [96].